“Increased Demand for HIV/AIDS Treatment”
A significant trend driving growth in the lopinavir/ritonavir market is the rising demand for effective HIV/AIDS treatment, particularly in low- and middle-income countries. As the global prevalence of HIV continues to rise, more governments and organizations are focusing on improving access to antiretroviral therapies (ART). Lopinavir/ritonavir, a combination drug, remains a cornerstone in HIV treatment regimens due to its strong antiviral effects and proven efficacy. For instance, the World Health Organization (WHO) continues to recommend this combination as part of the first-line treatment for adults and children, boosting demand. Additionally, ongoing efforts in prevention and treatment access programs have further accelerated the market's growth.
